XPHOZAH
Tracked across 1 events · 6 articles · First seen Aug 14, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Ardelyx reported Q2 2026 product revenue of $118.1 million and EPS of approximately $(0.07), both below consensus. The company lowered its full-year 2026 IBSRELA revenue guidance to $350-$370 million from $410-$430 million, citing increased payer…
Impact: XPHOZAH's long-term revenue target was withdrawn, though 2026 guidance was maintained. This signals reduced long-term growth expectations for the product.
Aug 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track XPHOZAH live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard